SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011548
Filing Date
2021-05-14
Accepted
2021-05-14 17:16:35
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 718414
2 ex31-1.htm EX-31.1 19280
3 ex31-2.htm EX-31.2 19081
4 ex32-1.htm EX-32.1 7578
5 ex32-2.htm EX-32.2 7724
  Complete submission text file 0001493152-21-011548.txt   4390765

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20210331.xml EX-101.INS 688162
7 XBRL SCHEMA FILE prph-20210331.xsd EX-101.SCH 51212
8 XBRL CALCULATION FILE prph-20210331_cal.xml EX-101.CAL 75705
9 XBRL DEFINITION FILE prph-20210331_def.xml EX-101.DEF 203761
10 XBRL LABEL FILE prph-20210331_lab.xml EX-101.LAB 374818
11 XBRL PRESENTATION FILE prph-20210331_pre.xml EX-101.PRE 302788
Mailing Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 21926004
SIC: 2834 Pharmaceutical Preparations